Case Reports in Medicine [3] V. E. Torres, S. B. Erickson, L. H. Smith, D. M. Wilson, R. R. Hattery, and J. W. Segura, “The association of nephrolithiasis and autosomal polycystic kidney disease,” American Journal of Kidney Diseases, vol. 11, no. 4, pp. 318–325, 1988. [4] V. E. Torres, D. M. Wilson, R. R. Hattery, and J. W. Segura, “Renal stone disease in autosomal dominant polycystic kidney disease,” American Journal of Kidney Diseases, vol. 22, no. 4, pp. 513–519, 1993. [5] D. Ravine, R. N. Gibson, R. G. Walker, L. J. Sheﬃeld, P. Kin- caid-Smith, and D. M. Danks, “Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease,” The Lancet, vol. 343, no. 8901, pp. 824–827, 1994. [6] M. S. Polinsky, B. A. Kaiser, and H. J. Baluarte, “Urolithiasis in childhood,” Pediatric Clinics of North America, vol. 34, no. 3, pp. 683–710, 1987. [7] G. F. Gibbs, J. Huston III, Q. Qian et al., “Follow-up of intra- cranial aneurysms in autosomal-dominant polycystic kidney disease,” Kidney International, vol. 65, no. 5, pp. 1621–1627, 2004. [8] D. Dimitrakov and S. Simeonov, “Studies on nephrolithiasis in patients with autosomal dominant polycystic kidney disease,” Folia Medica, vol. 36, no. 3, pp. 27–30, 1994. [9] S. A. Grampsas, P. S. Chandhoke, J. Fan et al., “Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease,” American Journal of Kidney Diseases, vol. 36, no. 1, pp. 53–57, 2000. [10] N. Hateboer, L. P. Lazarou, A. J. Williams, P. Holmans, and D. Ravine, “Familial phenotype diﬀerences in PKD1,” Kidney International, vol. 56, no. 1, pp. 34–40, 1999. 3